Patients with high tumor stage and heavy lymph node metastasis load are more likely to exhibit PSMA overexpression, and those with grade 3 HCC are more likely than those with grade 2 HCC to have peritumoral/vascular expression. Here, FOLH1 is linked to neoplasm.